The rise of AI has brought an avalanche of new terms and slang. Here is a glossary with definitions of some of the most ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
June 23, 2026 A bird long thought to be a single rare species in Japan has turned out to be two. Scientists discovered that the elusive Ijima’s Leaf Warbler and a newly identified Tokara Leaf Warbler ...
The compiler infers, but does not take instructions. There is no syntax for explicit type declarations yet, and the new type ...
Your institution does not have access to this book on JSTOR. Try searching on JSTOR for other items related to this book. https://doi.org/10.2307/j.ctvjnrt76.5 https ...
A solar tree is a structure resembling a tree that generates solar energy using photovoltaic (PV) panels. It employs principles of biomimicry, using a natural system—in this case the form of a tree—to ...
Recursion Pharmaceuticals (RXRX) has shown volatility recently, with a 3.13% decline on July 8, 2026, amidst broader market movements. The company is preparing for an earnings report, expected to show ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results